Office of Medical Communications

(NOVEMBER 10, 2022) Associate Professor of Pathology and Laboratory Medicine Margaret Doyle, Ph.D., was featured in a Vanderbilt University Medical Center VUMC Reporter article about a study she authored that showed an association between three types of CD4+ T helper cells and incident cardiovascular disease (CVD) among people with HIV infection.

(NOVEMBER 9, 2022) Vitamin D levels in patients with a deficiency and cystic fibrosis increased with a single high dose, according to a poster presented by Professor of Pediatrics Jillian S. Sullivan, M.D., and colleagues at the North American Cystic Fibrosis Conference held November 3-5 in Philadelphia, Healio News reported.

(NOVEMBER 8, 2022) Medical oncologist Kim Dittus, M.D., Ph.D., associate professor of medicine and director of the UVM Cancer Center’s Steps to Wellness exercise program for cancer survivors, was interviewed for a story about the Cancer Center being named Health.com’s Innovative Hospital Award Winner for 2022. Also interviewed was cancer survivor Evelyn Sikorski, manager of UVMMC’s employee health and wellness and employee assistance programs.

(NOVEMBER 8, 2022) Research on autism spectrum disorder conducted by Neuroscience Graduate Program doctoral student Erin Cullen and Assistant Professor of Neurological Sciences Matthew Weston, Ph.D., in collaboration with researchers at Dartmouth’s medical school, was featured in Chip Chick. (Click on headline for more.)

(NOVEMBER 7, 2022) Associate Professor of Pediatrics Rebecca Bell, M.D., answered RSV-related questions during a Facebook Live event on November 3, the (Plattsburg) Press-Republican reported.

(NOVEMBER 7, 2022) Stacey Sigmon, Ph.D., professor of psychiatry and director of the Center on Rural Addiction, was quoted in VTDigger discussing the increasing use of the animal sedative xylazine as a sought-after dilutant for opioids due to its effect of prolonging the “high” from using opioids.

(NOVEMBER 4, 2022) Professor of Surgery and UVMMC vascular surgeon Daniel J. Bertges, M.D., presented a clinical trial on paclitaxel drug-coated balloons (DCBs) at the VIVA Foundation’s VIVA22 conference in Las Vegas, according to CardiovascularBusiness.com.

(NOVEMBER 3, 2022) David Kaminsky, M.D., professor of medicine, spoke to The Other Paper’s Corey McDonald about so-called long COVID, following the death in May of a childhood friend of his own son who, after four months of increasingly debilitating symptoms that forced him to obtain a medical leave from his job, took his own life.

(NOVEMBER 3, 2022) Professor of Medicine Jan Carney, M.D., M.P.H., associate dean of public health and health policy, was quoted in US Today News commenting on a recent study by a medical informatics expert at the University of Illinois and colleagues on the possibility that Smartphones could one day collect data from a person’s daily cardio activity and predict risk of death, thus potentially providing an incentive to improve fitness.

(NOVEMBER 3, 2022) Health Commissioner and Professor of Medicine Mark Levine, M.D., was quoted in the Herald Chronicle speaking about a new partnership between the Vermont Department of Health and health care informatics company VisualDx -- whose CEO is Larner College of Medicine alumnus Art Papier, M.D.’88 -- to create a new “Clinician Support Initiative.”